Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin

Current Eye Research

Volumn 19, Issue 1, 1999, Pages 12-19

  Leitch, E C ^a   Willcox, M D P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Biofilm; Contact lens; Intraocular lens; Lactoferrin; Lysozyme; Staphylococcus epidermidis; Vancomycin

Indexed keywords

LACTOFERRIN; LYSOZYME; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SOFT CONTACT LENS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BIOFILMS; CONTACT LENSES, HYDROPHILIC; DRUG SYNERGISM; LACTOFERRIN; MURAMIDASE; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN;

EID: 0032991901     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.19.1.12.5342     Document Type: Article

References (38)

1. Driebe WT, Mandelbraum S, Forster RK, Schwartz LK and Culbertson WW. Pseudophakic endophthalmitis: diagnosis and management. Ophthalmology. 1986;93: 442-8.
2. Shrader SK, Band JD, Lauter CB and Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors and features influencing outcome. J Infect Dis. 1990;162:115-20.
3. Heaven CJ, Mann PJ and Boase DL. Endophthalmitis following extracapsular cataract surgery: a review of 32 cases. Br J Ophthalmol. 1992;76:419-23.
4. Cohen EJ, Gonzalez C, Leavitt KG, Arentsen JJ and Laibson PR. Corneal ulcers associated with contact lenses including experience with disposable lenses. CLAO J. 1991;17:173-176.
5. Leitch EC, Harmis NY, Corrigan KM and Willcox MDP. Identification and enumeration of staphylococci from the eye during soft contact lens wear. Optom Vis Sci. 1998;75:258-265.
6. Leitch EC and Willcox MDP. Lactoferrin and lysozyme exhibit synergistic anti-staphylococcal properties. J Med Microbiol. 1998;47:837-842.
7. Ellison III RT and Giehl TJ. Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest. 1991; 88:1080-1091.
8. Naidu AS and Arnold RR. Lactoferrin interaction with Salmonellae potentiates antibiotic susceptibility in vitro. Diag Microbiol Infect Dis. 1994;20:69-75.
9. Olsen JC, Flynn HW Jr, Forster RK and Culbertson WW. Results in the treatment of postoperative endophthalmitis. Ophthalmology. 1983;90:692-699.
10. Bode DD Jr, Gelender H and Forster RK. A retrospective review of endophthalmitis due to coagulase-negative staphylococci. Br J Ophthalmol. 1985;69:915-9.
11. Jett BD, Jensen HG, Atkuri RV and Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci. 1995;36:9-15.
12. Smith MA, Sorenson JA, Smith C, Miller M and Borenstein M. Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis. Antimicrob Agents Chemother. 1991;35: 1298-1302.
13. Rossetti SB and D'Alessandro LP. Antibiotic resistance of Staphylococcus spp. according to the source of ocular samples. Invest Ophthalmol Vis Sci Abstract Book. 1997; #2030.
14. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH and Kelsey SF. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122:1-17.
15. Gristina AG, Jennings RA, Naylor PT, Myrvik QN and Webb LX. Comparative in vitro antibiotic resistance of surface-colonizing coagulase negative staphylococci. Antimicrob Agents Chemother. 1989;33: 813-816.
16. Vergeres P and Blaser J. Amikacin, ceftazidine and flucloxacillin against suspended and adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an in vitro model of infection. J Infect Dis. 1992; 165:281-289.
17. Bergamini TM, McCurry TM, Bernard JD, Hoeg KL, Corpus RA, Peyton JC, Brittian KR and Cheadle WG. Antibiotic efficacy against Staphylococcus epidermidis adherent to vascular grafts. J Sur Res. 1996;60:3-6.
18. Leitch EC and Willcox MDP. Interactions between the constitutive host defences of tears and Staphylococcus epidermidis. Aust N Z Ophthalmol. 1997; (Suppl 1), 25:20-22.
19. Soboh F, Khoury AE, Zamboni AC, Davidson D and Mittelman MW. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 1995;39:1281-1286.
20. Watanakunakorn C. The antibacterial action of vancomycin. Rev Infect Dis. 1981; 3 (Suppl):210-215.
21. Spik G, Cheron A, Montreuil J and Dolby JM. Bacteriostasis of a milk-sensitive strain of Escherichia coli by immunoglobulins and iron-binding proteins in association. Immunology. 1978;35:663-671.
22. Carter P. Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem. 1971;40:450-458.
23. Christensen GD, Simpson WA Bisno AL and Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982;37:318-326.
24. Ellison RT III, Giehl TJ and LaForce FM. Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin. Infect Immun. 1988;56: 2774-2781.
25. Lee CK, Rubin LG and Moldwin RM. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms. Urology. 1995;45:720-724.
26. Teichman JM. Protamine sulphate and vancomycin are synergistic against Staphylococcus epidermidis prosthesis infections in vivo. J Ural. 1994;152:213-216.
27. Yeaman MR, Norman DC and Bayer AS. Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother. 1992;36:1665-1670.
28. Dunne WM. Jr, Mason EO. Jr and Kaplin SL. Diffusion of rifampicin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother. 1993;37:2522-2526.
29. Sanyal D, Williams AJ, Johnson AP and George RC. The emergence of vancomycin resistance in renal dialysis. J Hosp Infect. 1993;24:167-173.
30. Ginsburg I and Sela MN. The role of leukocytes and their hydrolases in the persistence, degradation and transport of bacterial constituents in tissues: relation to chronic inflammatory processes in staphylococcal, streptococcal and mycobacterial infections and in chronic periodontal disease. Crit Rev Microbiol. 1976;4:249-332.
31. Johansen C, Gill T and Gram L. Antibacterial effect of protamine assayed by impedimetry. J Appl Bacteriol. 1995;78:297-303.
32. Metcalf RH and Deibel RH. Growth of Streptococcus faecium in the presence of lysozyme. Infect Immun. 1972;6:178-183.
33. Evans RC and Holmes CJ. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother. 1987;31:889-894.
34. Leitch EC and Willcox MDP. Elucidation of the antistaphylococcal mechanism of lactoferrin and lysozyme. J Med Microbiol. 1999; In Press.
35. Sahm DF and Washington JA II. Antibacterial susceptibility tests: dilution methods. In Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, and Shadomy HJ eds. Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington DC; 1991: 1105-1116.
36. Homer P, Peyman GA, Koziol J and Sanders D. Intravitreal injection of vancomycin in experimental staphylococcal endophthalmitis. Acta Ophthalmol. 1975;53:311-320.
37. Smith MA, Sorenson JA, Lowy FD, Shaku JL, Harrison W and Jakbiec FA. Treatment of experimental methicillin-resistant S. epidermidis endophthalmitis with intravitreal vancomycin. Ophthalmology. 1986;93:1328-1335.
38. Pflugfelder SC, Hernandez E, Fliesler SJ, Alvarez J, Pflugfelder ME and Forster RK. Intravitreal vancomycin. Arch Ophthalmol. 1987;105:831-837.